Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Buy GB Group (GBG) by Hot Stock Rockets in ShareProphets
- Avoid The Mission Group (TMG) by Steve Moore in ShareProphets
- Avoid Videndum (VID) by Steve Moore in ShareProphets
- Hold Frasers Group (FRAS) by Shore Capital
- Hold The Magnum Ice Cream Company (MICC) by Berenberg
- Buy Zigup (ZIG) by Berenberg
- Neutral GSK (GSK) by Citi
- Neutral Rio Tinto (RIO) by Citi
- Neutral Standard Chartered (STAN) by UBS
- Buy Centrica (CNA) by Citi
- Overweight Centrica (CNA) by JP Morgan
- Hold Anglo American (AAL) by Berenberg
- Buy Relx plc (REL) by Deutsche Bank
- Underweight Admiral Group (ADM) by JP Morgan
- Buy Morgan Sindall Group (MGNS) by Deutsche Bank
- Hold Jupiter Fund Management (JUP) by Deutsche Bank
- Buy Hill and Smith (HILS) by Peel Hunt
- Hold HSBC Holdings (HSBA) by Shore Capital
- Buy Chesnara (CSN) by Berenberg
- Buy Victoria (VCP) by Berenberg
Hikma Pharmaceuticals (HIK) Share Price
Health Care Sector
NOTE: This is based on 393 open tips for Hikma Pharmaceuticals (HIK)
| Latest Bid : 1,573.00p | Latest Ask : 1,575.00p |
| High Today : 1,584.00p | Low Today : 1,531.00p |
| This Years High : 2,028.00p | This Years Low : 1,191.00p |
| Volume : 248,142 | MKT Cap : £3496.22M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Hikma Pharmaceuticals (HIK) Overview
Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikma's operations are in the United States, the Middle East and North Africa Region and Europe.Hikma Pharmaceuticals (HIK) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | Citi | Premium Only | 2026-07-16 10:00:00 16/07/2026 | 4.28% |
| Buy | Deutsche Bank | Premium Only | 2026-06-22 14:15:00 22/06/2026 | -0.27% |
| Buy | Jefferies | Premium Only | 2026-05-05 04:25:00 05/05/2026 | 11.41% |
| Buy | Berenberg | Premium Only | 2026-04-28 10:31:00 28/04/2026 | 14.27% |
| Buy | Berenberg | Premium Only | 2026-03-04 15:31:00 04/03/2026 | 26.36% |
Hikma Pharmaceuticals (HIK) Active Short Positions
| Fund Manager | Position | Date |
|---|---|---|
| Kintbury Capital LLP | 1.88% | 08/07/2026 |
| Latest Bid : 1,573.00p | Latest Ask : 1,575.00p |
| High Today : 1,584.00p | Low Today : 1,531.00p |
| This Years High : 2,028.00p | This Years Low : 1,191.00p |
| Volume : 248,142 | MKT Cap : £3496.22M |
Hikma Pharmaceuticals Overview
Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikma's operations are in the United States, the Middle East and North Africa Region and Europe.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Hikma Pharmaceuticals Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | Citi | Premium Only | 2026-07-16 10:00:00 16/07/2026 | 4.28% |
| Buy | Deutsche Bank | Premium Only | 2026-06-22 14:15:00 22/06/2026 | -0.27% |
| Buy | Jefferies | Premium Only | 2026-05-05 04:25:00 05/05/2026 | 11.41% |
| Buy | Berenberg | Premium Only | 2026-04-28 10:31:00 28/04/2026 | 14.27% |
| Buy | Berenberg | Premium Only | 2026-03-04 15:31:00 04/03/2026 | 26.36% |